These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30530118)

  • 21. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.
    Nazareth TA; Rava AR; Polyakov JL; Banfe EN; Waltrip Ii RW; Zerkowski KB; Herbert LB
    Mult Scler Relat Disord; 2018 Nov; 26():219-234. PubMed ID: 30368080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.
    Ehde DM; Alschuler KN; Osborne TL; Hanley MA; Jensen MP; Kraft GH
    Disabil Health J; 2015 Jul; 8(3):452-6. PubMed ID: 25899795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geographic Disparities in Access to Neurologists and Multiple Sclerosis Care in the United States.
    McGinley MP; Harvey T; Lopez R; Ontaneda D; Buchalter RB
    Neurology; 2024 Jan; 102(2):e207916. PubMed ID: 38165332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Socioeconomic, health-care access and clinical determinants of disease severity in Multiple Sclerosis in Chile.
    Ciampi E; Soler B; Uribe-San-Martin R; Jürgensen L; Guzman I; Keller K; Reyes A; Bravo-Grau S; Cruz JP; Cárcamo C
    Mult Scler Relat Disord; 2023 Oct; 78():104918. PubMed ID: 37562199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disability in two health care systems: access, quality, satisfaction, and physician contacts among working-age Canadians and Americans with disabilities.
    Gulley SP; Altman BM
    Disabil Health J; 2008 Oct; 1(4):196-208. PubMed ID: 21122730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition.
    Solomon AJ; Marrie RA; Viswanathan S; Correale J; Magyari M; Robertson NP; Saylor DR; Kaye W; Rechtman L; Bae E; Shinohara R; King R; Laurson-Doube J; Helme A
    Neurology; 2023 Aug; 101(6):e624-e635. PubMed ID: 37321866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does age at diagnosis influence the use of health services for multiple sclerosis?
    Mésidor M; Sylvestre MP; Marrie RA; Rousseau MC
    Mult Scler Relat Disord; 2020 Nov; 46():102555. PubMed ID: 33045495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?
    Schwartz CE; Quaranto BR; Healy BC; Benedict RH; Vollmer TL
    Arch Phys Med Rehabil; 2013 Oct; 94(10):1971-81. PubMed ID: 23727344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engagement in volunteering activities by persons with multiple sclerosis in Switzerland.
    Mettler M; Stanikić M; Schwegler U; Sieber C; Ajdacic-Gross V; Rodgers S; Haag C; Zecca C; Calabrese P; Kägi S; Rapold I; von Wyl V;
    Mult Scler Relat Disord; 2023 Jan; 69():104427. PubMed ID: 36470169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis diagnosis delay and its associated factors among Iranian patients.
    Mobasheri F; Jaberi AR; Hasanzadeh J; Fararouei M
    Clin Neurol Neurosurg; 2020 Dec; 199():106278. PubMed ID: 33069931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steps per day among persons with multiple sclerosis: variation by demographic, clinical, and device characteristics.
    Dlugonski D; Pilutti LA; Sandroff BM; Suh Y; Balantrapu S; Motl RW
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1534-9. PubMed ID: 23419331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urban/rural differences in access and barriers to health care for people with multiple sclerosis.
    Buchanan RJ; Stuifbergen A; Chakravorty BJ; Wang S; Zhu L; Kim M
    J Health Hum Serv Adm; 2006; 29(3):360-75. PubMed ID: 17571473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity.
    Puhan MA; Steinemann N; Kamm CP; Müller S; Kuhle J; Kurmann R; Calabrese P; Kesselring J; von Wyl V; Swiss Multiple Sclerosis Registry Smsr
    Swiss Med Wkly; 2018; 148():w14623. PubMed ID: 29767828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
    O'Connell K; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt.
    Zakaria M; Zamzam DA; Abdel Hafeez MA; Swelam MS; Khater SS; Fahmy MF; Abdel Hady A; Fouad MM; Abdel Nasser A; Aref H; Gadallah M
    Mult Scler Relat Disord; 2016 Nov; 10():30-35. PubMed ID: 27919495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of sociodemographic characteristics on diagnosis and access to disease-modifying treatment for patients with multiple sclerosis in Morocco.
    Lotfi R; Chigr F; Najimi M
    Mult Scler Relat Disord; 2022 Nov; 67():104193. PubMed ID: 36179556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mining healthcare data for markers of the multiple sclerosis prodrome.
    Högg T; Wijnands JMA; Kingwell E; Zhu F; Lu X; Evans C; Fisk JD; Marrie RA; Zhao Y; Tremlett H
    Mult Scler Relat Disord; 2018 Oct; 25():232-240. PubMed ID: 30121490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
    Krause I; Kern S; Horntrich A; Ziemssen T
    Mult Scler; 2013 Nov; 19(13):1792-9. PubMed ID: 23635910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey.
    Drulovic J; Basic-Kes V; Grgic S; Vojinovic S; Dincic E; Toncev G; Kezic MG; Kisic-Tepavcevic D; Dujmovic I; Mesaros S; Miletic-Drakulic S; Pekmezovic T
    Pain Med; 2015 Aug; 16(8):1597-602. PubMed ID: 26087108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.